EyeArt
Eyenuk
FDA cleareddiabetic retinopathydiabetic macular edemaAMDglaucoma
Cloud-based autonomous AI that grades retinal photographs for diabetic retinopathy, including a separate vision-threatening call. The vendor also markets detection of AMD and glaucomatous optic nerve signs under its EU certification.
FDA clearance covers diabetic retinopathy only.
- Company
- Eyenuk
- Category
- Screening
- Reads
- Color fundus photographs from supported cameras (FDA labeling lists Canon CR-2 AF/CR-2 Plus AF and Topcon NW400)
- Built for
- Primary care, diabetes centers, optometry and ophthalmology clinics
- Billing
- Check vendor (vendor product page does not state a CPT code)
- Regulatory
- FDA 510(k) K200667 (Aug 3, 2020); 510(k) K223357 EyeArt v2.2.0 (Jun 16, 2023). FDA clearance is for diabetic retinopathy only (product code PIB). Vendor also claims EU MDR Class IIb certification for DR, AMD and glaucomatous optic nerve damage (not independently verified). · source
- Last verified
- 2026-10-07
DotAEye is independent of Eyenuk. Confirm indications, intended use, and clearance status with the manufacturer before clinical use.